Curcumin induces cleavage of β-catenin by activation of capases and downregulates the β-catenin/Tcf signaling pathway in HT-29 cells

African Journal of Biotechnology

Volumn 8, Issue 20, 2009, Pages 5516-5522

  Qi, L L ^a   Wang, J B ^a,b   Wang, H Z ^a   Luo, Y T ^a   Wu, T X ^b  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

catenin Tcf signaling pathway; Curcumin; HT 29 cells

Indexed keywords

BENZYLOXYCARBONYL ASPARTYLGLUTAMYLVALYLASPARTIC ACID FLUOROMETHYL KETONE; BETA CATENIN; CASPASE; CASPASE INHIBITOR; CURCUMIN; CYCLIN D1; MYC PROTEIN; T CELL FACTOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL NUCLEUS; CELL STRAIN HT29; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 73349097233     PISSN: None     EISSN: 16845315     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Polakis P (2000). Wnt signaling and cancer. Genes Dev. 14(15): 1837-1851.
2. Rubinfeld B, Albert I, Porfiri E, Fiol C, Munemitsu S, Polakis P (1996). Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly. Science, 272(5264): 1023-1026.
3. Staal FJ, Noort Mv M, Strous GJ, Clevers HC (2002). Wnt signals are transmitted through N-terminally dephosphorylated beta-catenin. EMBO Rep. 3(1): 63-68.
4. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, Costa LT, Morin PJ, Vogelstein B, Kinzler KW (1998). Identification of c-MYC as a target of the APC pathway. Science, 281(5382): 1509-1512.
5. He C, Hu H, Braren R, Fong SY, Trumpp A, Carlson TR, Wang RA (2008). c-myc in the hematopoetic lineage is crucial for its angiogenic function in the mouse embryo. Development, 135(14): 2467-2477.
6. Tetsu O, McCormick F (1999). Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature, 398(6726): 422-426.
7. Mann B, Gelos M, Siedow A, Hanski ML, Gratchev A, Ilyas M, Bodmer WF, Moyer MP, Riecken EO, Buhr HJ, Hanski C (1999). Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. Proc. Natl. Acad. Sci. USA, 96(4): 1603-1608.
8. Morin PJ, Vogelstein B, Kinzler KW (1996). Apoptosis and APC in colorectal tumorigenesis. Proc. Natl. Acad. Sci. USA, 93(4): 7950-7954.
9. Bright-Thomas RM, Hargest R (2003). APC, beta-Catenin and hTCF-4; an unholy trinity in the genesis of colorectal cancer. Eur. J. Surg. Oncol. 29(2): 107-117.
10. Shishodia S, Sethi G, Aggarwal BB (2005). Curcumin: getting back to the roots. Ann. N.Y. Acad. Sci. 1056: 206-217.
11. Shishodia S, Singh T, Chaturvedi MM (2007). Modulation of transcription factors by curcumin. Adv. Exp. Med. Biol. 595: 127-148.
12. Bhaumik S, Jyothi MD, Khar A (2000). Differential modulation of nitric oxide production by curcumin in host macrophages and NK cells. FEBS Lett. 483(1): 78-82.
13. Sen S, Sharma H, Singh N (2005). Curcumin enhances Vinorelbine mediated apoptosis in NSCLC cells by the mitochondrial pathway. Biochem. Biophys. Res. Commun. 331: 1245-1252.
14. Goel A, Kunnumakkara AB, Aggarwal BB (2008). Curcumin as Curecumin: from kitchen to clinic. Biochem. Pharmacol. 75: 787-809.
15. Aggarwal S, Ichikawa H, Takada Y, Sandur SK, Shishodia S, Aggarwal BB (2006). Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IκBα kinase and Akt activation. Mol. Pharmacol. 69: 195-206.
16. Jaiswal AS, Marlow BP, Gupta N, Narayan S (2002). Beta-catenin-mediated transactivation and cell-cell adhesion pathways are important in curcumin (diferuylmethane)-induced growth arrest and apoptosis in colon cancer cells. Oncogene, 21: 8414-8427.
17. Park CH, Hahm ER, Park S, Kim H, Yang CH (2005). The inhibitory mechanism of curcumin and its derivative against β-catenin/Tcf signaling. FEBS Lett. 579: 2965-2971.
18. Bordonaro M, Mariadason JM, Aslam F, Heerdt BG, Augenlicht LH (1999). Butyrate-induced apoptotic cascade in colonic carcinoma cells: modulation of the β-Catenin-Tcf pathway and concordance with effects of sulindac and trichostatin A but not curcumin. Cell Growth Differ. 10: 713-720.
19. Yan BZ, Wang W, Chen LY, Bi MR, Lu YJ, Li BX, Yang BS (2009). Role of cathepsin B-mediated apoptosis in fulminant hepatic failure in mice. World J. Gastroenterol. 15(10): 1231-1236.
20. Steinhusen U, Badock V, Bauer A, Behrens J, Wittman-Liebold B, Dorken B, Bommert K (2000). Apoptosis-induced cleavage of beta-catenin by caspase-3 results in proteolytic fragments with reduced transactivation potential. J. Bio. Chem. 275: 16345-16353.
21. Molenaar M, Wetering M, Oosterwegel M, Peterson-Maduro J, Godsave S, Korinek V, Roose J, Destree O, Clevers H (1996). XTcf-3 transcription factor mediates β-catenin-induced axis formation in Xenopus embryos. Cell, 86: 391-399.
22. Arber N, Hibshoosh H, Moss SF, Sutter T, Zhang Y, Begg M, Wang S, Weinstein IB, Holt PR (1996). Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis. Gastroenterology, 110: 669-674.
23. Arber N, Doki Y, Han EK, Sgambato A, Zhou P, Kim NH, Delohery T, Klein MG, Holt PR, Weinstein IB (1997). Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells. Cancer Res. 57: 1569-1574.
24. Wang JB, Qi LL, Zheng SD, Wu TX (2009). Curcumin induces apoptosis through the mitochondria-mediated apoptotic pathway in HT-29 cells. J. Zhejiang Univ. Sci. B 10(2): 93-102.
25. Schorl C, Sedivy JM (2003). Loss of protooncogene c-Myc function impedes G1 phase progression both before and after the restriction point. Mol. Biol. Cell, 14: 823-835.